PDS Biotechnology Corpora... (PDSB)
1.22
-0.11 (-8.27%)
At close: Mar 03, 2025, 12:17 PM
PDS Biotechnology Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 56.56M | 73.82M | 65.24M | 28.84M | 12.16M | 34.65M | 88.07M | 106.4M | 130.19M | 13.73M | 7.86M | 140.93K |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | n/a | 0.00 | 0.00 | -0.00 | -0.00 | 142.87K | 96.06K | 90.95K | 55.16K | 160.68K | 63.93K | 8.77K |
| Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 459.02K | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 2.49M | 2.66M | 1.6M | 1.5M | 2.31M | 1.01M | 50.9K | 130.99K | 1.08M | 1.62M | 212.63K | 6.46K |
| Total Current Assets | 59.06M | 76.48M | 66.84M | 30.34M | 14.47M | 35.65M | 89.05M | 107.35M | 131.27M | 15.44M | 8.53M | 147.39K |
| Property-Plant & Equipment | 335K | 527.53K | 357.7K | 553.15K | 21.05K | 426.95K | 3.42M | 3.42M | 2.77M | 1.44M | 140.04K | 7.59K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | 46.8K | 51.92K | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 335K | 527.53K | 357.7K | 553.15K | 21.05K | 569.82K | 3.57M | 3.56M | 2.82M | 1.6M | 203.97K | 16.36K |
| Total Assets | 59.39M | 77.01M | 67.2M | 30.89M | 14.49M | 36.22M | 92.62M | 110.91M | 134.09M | 17.05M | 8.73M | 163.76K |
| Account Payables | 6.98M | 1.22M | 1.31M | 1.42M | 1.2M | 399.45K | 4.37M | 3.47M | 2.58M | 2.05M | 1.09M | n/a |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 25K | 6.84K | 34.39K | -265.26K | n/a | 7.49K |
| Short-Term Debt | 4.22M | 288.04K | 258.92K | 119.9K | n/a | n/a | 3.08M | n/a | -313.14K | 265.26K | n/a | 172.05K |
| Other Current Liabilities | 2.42M | 8.31M | 2.19M | 1.74M | 1.6M | 5.98M | 5.42M | 3.21M | 3.7M | 1.58M | 690.99K | 3.34M |
| Total Current Liabilities | 13.63M | 9.82M | 3.76M | 3.27M | 2.79M | 6.38M | 12.87M | 6.68M | 8.59M | 3.89M | 1.79M | 3.52M |
| Long-Term Debt | 19.63M | 23.18M | 231.43K | 490.35K | n/a | 30K | 17.38M | 14.95M | 3.03M | 2.53M | n/a | 27.14K |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | 291.23K | n/a | n/a | n/a | 38.46M | 22.3M | n/a |
| Total Long-Term Liabilities | 19.63M | 23.18M | 231.43K | 490.35K | n/a | 321.23K | 17.38M | 14.95M | 3.03M | 40.99M | 22.3M | 27.14K |
| Total Liabilities | 33.26M | 33.01M | 3.99M | 3.76M | 2.79M | 6.38M | 30.25M | 21.64M | 11.62M | 44.88M | 24.08M | 3.55M |
| Total Debt | 23.85M | 23.47M | 490.35K | 610.26K | n/a | 30K | 20.46M | 14.95M | 5.3M | 2.79M | n/a | 199.19K |
| Common Stock | 10.92K | 9.96K | 9.39K | 7.35K | 1.74K | 10.59K | 10.4K | 9.76K | 9.72K | 770.00 | 770.00 | 770.00 |
| Retained Earnings | -144.5M | -101.56M | -60.7M | -43.79M | -28.94M | -192.82M | -151.95M | -101.07M | -62.25M | -29.82M | -16.04M | -8.08M |
| Comprehensive Income | n/a | 0.00 | 0.00 | 0.00 | n/a | -451.66K | -305.28K | -122.36K | -91.39K | -38.28K | -7.05K | n/a |
| Shareholders Equity | 26.13M | 44M | 63.21M | 27.13M | 11.7M | 29.84M | 62.37M | 89.28M | 122.48M | -27.83M | -15.35M | -3.38M |
| Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |